Background Plasmodium vivax infects an estimated 7 million people every year. Previously,
vivax malaria was perceived as a benign condition, particularly when compared to …

In areas where Plasmodium falciparum transmission is endemic, clinical immunity against
malaria is progressively acquired during childhood and adults are usually protected against …

Background The most recent global estimates of the number of pregnancies at risk of
Plasmodium falciparum and Plasmodium vivax malaria infection are from 2007. To inform …

Abstract Background In sub-Saharan Africa, the efficacy of intermittent preventive therapy in
pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) for malaria in pregnancy is …

ABSTRACT Malaria in Pregnancy (MiP) leading to morbidity and mortality is a major public
health problem that poses significant risk to pregnant women and their fetus. To cope with …

Background In malaria-endemic areas, pregnant women and especially first-time mothers
are more susceptible to Plasmodium falciparum. Malaria diagnosis is often missed during …

Vector‐borne diseases (VBDs) are embedded within complex socio‐ecological systems.
While research has traditionally focused on the direct effects of VBDs on human morbidity …

Vaccinations during pregnancy can protect the mother from several infections, thus blocking
vertical transmission. Furthermore, through passive antibody transfer, the newborn can be …

Malaria is one of the most serious infectious diseases affecting predominantly low-and
middle-income countries, where pregnant women are among the populations at risk. There …

Background Artemisinin and artemisinin-based combination therapy (ACT) partner drug
resistance in Plasmodium falciparum have spread across the Greater Mekong Subregion …